NDST-1 modulates BMPR and PTHrP signaling during endochondral bone formation in a gene knockout model

Bone

Volumn 40, Issue 6, 2007, Pages 1462-1474

  Hu, Zhonghua ^a   Yu, Mingyan ^b   Hu, Gengxi ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

BMP; Delay; Endochondral bone formation; NDST 1; PTHrP

Indexed keywords

ACYLTRANSFERASE; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 6; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 3; HEPARAN SULFATE; N DEACETYLASE; NOGGIN; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN PATCHED; SMAD1 PROTEIN; SONIC HEDGEHOG PROTEIN; SULFOTRANSFERASE; SULFOTRANSFERASE 1; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BIOSYNTHESIS; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYO; ENCHONDRAL OSSIFICATION; ENZYME MECHANISM; FEMALE; GENE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIMB; MODEL; MODULATION; MOUSE; MUTANT; NEWBORN; NONHUMAN; PHALANX; PROTEIN BINDING; RECEPTOR UPREGULATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS; EXTREMITIES; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; ORGAN CULTURE TECHNIQUES; OSTEOGENESIS; PARATHYROID HORMONE-RELATED PROTEIN; SIGNAL TRANSDUCTION; SULFOTRANSFERASES;

EID: 34248631964     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.01.021     Document Type: Article

References (77)

1. Bernfield M., Götte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., et al. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68 (1999) 729-777
2. Ornitz D.M. FGFs, heparan sulfate and FGFRs: complex interactions essential for development. BioEssays 22 (2000) 108-112
3. Park P.W., Reizes O., and Bernfield M. Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J. Biol. Chem. 275 (2000) 29923-29926
4. Rapraeger A.C., Krufka A., and Olwin B.B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252 (1991) 1705-1708
5. Lyon M., Deakin J.A., Mizuno K., Nakamura T., and Gallagher J.T. Interaction of hepatocyte growth factor with heparan sulfate. J. Biol. Chem. 269 (1994) 11216-11223
6. McCaffrey T.A., Falcone D.J., Brayton C.F., Agarwal L.A., Welt F.G.P., and Weksler B.B. Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex. J. Cell Biol. 109 (1989) 441-448
7. McCaffrey T.A., Falcone D.J., Vicente D., Du B., Consigli S., and Borth W. Protection of transforming growth factor-beta 1 activity by heparin and fucoidan. J. Cell Physiol. 159 (1994) 51-59
8. Esko J.D., and Selleck S.B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71 (2002) 435-471
9. Lindahl U., Kusche-Gullberg M., and Kjellén L. Regulated diversity of heparan sulfate. J. Biol. Chem. 273 (1998) 24979-24982
10. Salmivirta M., Lidholt K., and Lindahl U. Heparan sulfate: a piece of information. FASEB J. 10 (1996) 1270-1279
11. Aikawa J., and Esko J.D. Molecular cloning and expression of a third member of the heparan Sulfate/Heparin GlcNAc N-Deacetylase/N-Sulfotransferase Family. J. Biol. Chem. 274 (1999) 2690-2695
12. Aikawa J., Grobe K., Tsujimoto M., and Esko J.D. Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4. J. Biol. Chem. 276 (2001) 5876-5882
13. Eriksson I., Sandbäck D., Ek B., Lindahl U., and Kjellén L. cDNA cloning and sequencing of mouse mastocytoma glucosaminyl N-deacetylase/N-sulfotransferase, an enzyme involved in the biosynthesis of heparin. J. Biol. Chem. 269 (1994) 10438-10443
14. Hashimoto Y., Orellana A., Gil G., and Hirschberg C.B. Molecular cloning and expression of rat liver N-heparan sulfate sulfotransferase. J. Biol. Chem. 267 (1992) 15744-15750
15. Kusche-Gullberg M., Eriksson I., Pikas D.S., and Kjellén L. Identification and expression in mouse of two heparan sulfate glucosaminyl N-Deacetylase/N-Sulfotransferase genes. J. Biol. Chem. 273 (1998) 11902-11907
16. Binari R.C., Staveley B.E., Johnson W.A., Godavarti R., Sasisekharan R., and Manoukian A.S. Genetic evidence that heparin-like glycosaminoglycans are involved in wingless signaling. Development 124 (1997) 2623-2632
17. Bellaiche Y., The I., and Perrimon N. Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature 394 (1998) 85-88
18. Haerry T.E., Heslip T.R., Marsh J.L., and O'Connor M.B. Defects in glucuronate biosynthesis disrupt Wingless signaling in Drosophila. Development 124 (1997) 3055-3064
19. Häcker U., Lin X., and Perrimon N. The Drosophila sugarless gene modulates Wingless signaling and encodes an enzyme involved in polysaccharide biosynthesis. Development 124 (1997) 3565-3573
20. Lin X., and Perrimon N. Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signaling. Nature 400 (1999) 281-284
21. Lin X., Buff E.M., Perrimon N., and Michelson A.M. Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126 (1999) 3715-3723
22. Lin X., and Perrimon N. Developmental roles of heparan sulfate proteoglycans in Drosophila. Glycoconjugate J. 19 (2003) 363-368
23. The I., Bellaiche Y., and Perrimon N. Hedgehog movement is regulated through tout velu-dependent synthesis of a heparan sulfate proteoglycan. Mol. Cell 4 (1999) 633-639
24. Tsuda M., Kamimura K., Nakato H., Archer M., Staatz W., Fox B., et al. The cell-surface proteoglycan Dally regulates Wingless signaling in Drosophila. Nature 400 (1999) 276-280
25. Forsberg E., Pejler G., Ringvall M., Lunderius C., Tomasini-Johansson B., Kusche-Gullberg M., et al. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400 (1999) 773-776
26. Humphries D.E., Wong G.W., Friend D.S., Gurish M.F., Qiu W.T., Huang C., et al. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 400 (1999) 769-772
27. Fan G., Xiao L., Cheng L., Wang X., Sun B., and Hu G. Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett. 467 (2000) 7-11
28. Ringvall M., Ledin J., Holmborn K., Van Kuppevelt T., Ellin F., Eriksson I., et al. Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-Deacetylase/N-Sulfotransferase-1. J. Biol. Chem. 275 (2000) 25926-25930
29. Grobe K., Inatani M., Pallerla S.R., Castagnola J., Yamaguchi Y., and Esko J.D. Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function. Development 132 (2005) 3777-3786
30. Olsen B.R., Reginato A.M., and Wang W. Bone development. Annu. Rev. Cell Dev. Biol. 16 (2000) 191-220
31. Lanske B., Karaplis A.C., Lee K., Luz A., Vortkamp A., Pirro A., et al. PTH/PTHrP receptor in early development and Indian Hedgehog-regulated bone growth. Science 273 (1996) 663-666
32. St-Jacques B., Hammerschmidt M., and McMahon A.P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13 (1999) 2072-2086
33. Vortkamp A., Lee K., Lanske B., Segre G.V., Kronenberg H.M., and Tabin C. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273 (1996) 663-666
34. Noonan K.J., Hunziker E.B., Nessler J., and Buckwalter J.A. Changes in cell, matrix compartment, and fibrillar collagen volumes between growth-plate zones. J. Orthop. Res. 16 (1998) 500-508
35. Minina E., Wenzel H.M., Kreschel C., Karp S., Gaffield W., Mcmahon A.P., et al. BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development 128 (2001) 4523-4534
36. Pathi S., Rutenberg J.B., Johnson R.L., and Vortkamp A. Interaction of Ihh and BMP/Noggin signaling during cartilage differentiation. Dev. Biol. 209 (1999) 239-253
37. Zou H., Wieser R., Massague J., and Niswander L. Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. Genes Dev. 11 (1997) 2191-2203
38. Friedl A., Chang Z., Tierney A., and Rapraeger A.C. Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues. Am. J. Pathol. 150 (1997) 1443-1455
39. Chang Z., Meyer K., Rapraeger A.C., and Friedl A. Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ. FASEB J. 14 (2000) 137-144
40. Serra R., Karaplis A., and Sohn P. Parathyroid Hormone-related Peptide (PTHrP)-dependent and -independent effects of transforming growth factor-β (TGF-β) on endochondral bone formation. J. Cell Biol. 145 (1999) 783-794
41. Linsenmayer T.F., Chen Q.A., Gibney E., Gordon M.K., Marchant J.K., Mayne R., et al. Collagen type IX and X in the developing chick tibiotarsus: analyses of mRNA and proteins. Development 111 (1991) 191-196
42. Elima K., Eerola I., Rosati R., Metsaranta M., Garofalo S., Perala M., et al. The mouse collagen X gene: complete nucleotide sequence, exon structure and expression pattern. Biochem. J. 289 (1993) 247-253
43. Nomura S., Wills A.J., Edwards D.R., Heath J.K., and Hogan B.L.M. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 106 (1988) 441-450
44. Chen J., Zhang Q., Mcculloch C.A.G., and Sodek J. Immunohistochemical localization of bone sialoprotein in foetal porcine bone tissues: comparisons with secreted phosphoprotein 1 (SPP-1, osteopontin) and SPARC (osteonectin). Histochem. J. 23 (1991) 281-289
45. Ducy P., Zhang R., Geoffroy V., Ridall A., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
46. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 55-764
47. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 (1997) 765-771
48. Nohe A., Hassel S., Ehrlich M., Neubauer F., Sebald W., Henis Y.I., et al. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J. Biol. Chem. 277 (2002) 5330-5338
49. Arikawa-Hirasawa E., Watanabe H., Takami H., Hassell J.R., and Yamada Y. Perlecan is essential for cartilage and cephalic development. Nat. Genet. 23 (1999) 354-358
50. Zimmerman L.B., De Jesus-Escobar J.M., and Harland R.M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86 (1996) 599-606
51. Bai X., and Esko J.D. An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation. J. Biol. Chem. 271 (1996) 17711-17717
52. Maccarana M., Casu B., and Lindahl U. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J. Biol. Chem. 268 (1993) 23898-23905
53. Turnbull J.E., Fernig D.G., Ke Y., Wilkinson M.C., and Gallagher J.T. Identification of the basic Fibroblast Growth Factor binding sequence in fibroblast heparan sulfate. J. Biol. Chem. 267 (1992) 10337-10341
54. Guimond S., Maccarana M., Olwin B.B., Lindahl U., and Rapraeger A.C. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem. 268 (1993) 23906-23914
55. Irie A., Habuchi H., Kimata K., and Sanai Y. Heparan sulfate is required for bone morphogenetic protein-7 signaling. Biochem. Biophys. Res. Commun. 308 (2003) 858-865
56. Ruppert R., Hoffmann E., and Sebald W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 237 (1996) 295-302
57. Bornemann D.J., Duncan J.E., Staatz W., Selleck S., and Warrior R. Abrogation of heparan sulfate synthesis in Drosophila disrupts the Wingless, Hedgehog and Decapentaplegic signaling pathways. Development 131 (2004) 1927-1938
58. Han C., Belenkaya T.Y., Khodoun M., Tauchi M., and Lin X. Distinct and collaborative roles of Drosophila EXT family proteins in morphogen signaling and gradient formation. Development 131 (2004) 1563-1575
59. Takei Y., Ozawa Y., Sato M., Watanabe A., and Tabata T. Three Drosophila EXT genes shape morphogen gradients through synthesis of heparan sulfate proteoglycans. Development 131 (2004) 73-82
60. Belenkaya T.Y., Han C., Yan D., Opoka R., Khodoun M., Liu H., et al. Drosophila Dpp morphogen movement is independent of Dynamin-mediated endocytosis, but regulated by the glypican members of heparan sulfate proteoglycans. Cell 119 (2004) 231-244
61. Ohkawara B., Iemura S., ten Dijke P., and Ueno N. Action range of BMP is defined by its N-terminal basic amino acid core. Curr. Biol. 12 (2002) 205-209
62. Paine-Saunders S., Viviano B.L., Economides A.N., and Saunders S. Heparan sulfate proteoglycans retain noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J. Biol. Chem. 277 (2002) 2089-2096
63. Grisaru S., Cano-Gauci D., Tee J., Filmus J., and Rosenblum N.D. Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis. Dev. Biol. 231 (2001) 31-46
64. Fisher M.C., Li Y., Seghatoleslami M.R., Dealy C.N., and Kosher R.A. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. Matrix Biol. 25 (2006) 27-39
65. Brunet L.J., McMahon J.A., McMahon A.P., and Harland R.M. Noggin cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280 (1998) 1455-1457
66. Capdevila J., and Johnson R.L. Endogenous and ectopic expression of noggin suggests a conserved mechanism for regulation of BMP function during limb and somite patterning. Dev. Biol. 197 (1998) 205-217
67. Nakayama N., Han C., Scully S., Nishinakamura R., He C., Zeni L., et al. A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages. Dev. Biol. 232 (2001) 372-387
68. Zhang D., Ferguson C.M., O'Keefe R.J., Puzas J.E., Rosier R.N., and Reynolds P.R. A role for the BMP antagonist chordin in endochondral ossification. J. Bone Miner. Res. 17 (2002) 293-300
69. Jasuja R., Allen B.L., Pappano W.N., Rapraeger A.C., and Greenspan D.S. Cell-surface heparin sulfate proteoglycans potentiate chordin antagonism of bone morphogenetic protein signaling and are necessary for cellular uptake of chordin. J. Biol. Chem. 279 (2004) 51289-51297
70. Minina E., Kreschel C., Naski M.C., Ornitz D.M., and Vortkamp A. Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev. Cell 3 (2002) 439-449
71. Karp S.J., Schipani E., St-Jacques B., Hunzelman J., Kronenberg H., and McMahon A.P. Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development 127 (2000) 543-548
72. Amizuka N., Warshawsky H., Henderson J.E., Goltzman D., and Karaplis A.C. Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J. Cell Biol. 126 (1994) 1611-1623
73. Karaplis A.C., Luz A., Glowacki J., Bronson R.T., Tybulewicz V.L., Kronenberg H.M., et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 8 (1994) 277-289
74. Weir E.C., Philbrick W.M., Amling M., Neff L.A., Baron R., and Broadus A.E. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 10240-10245
75. Schipani E., Kruse K., and Jüppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268 (1995) 98-100
76. Koziel L., Kunath M., Kelly O.G., and Vortkamp A. Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification. Dev. Cell 6 (2004) 801-813
77. Takada T., Katagiri T., Ifuku M., Morimura N., Kobayashi M., Hasegawa K., et al. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J. Biol. Chem. 278 (2003) 43229-43235